Cyclooxygenase-2 expression in malignant mesenchymal tumors and related uterine lesions

Oncology Reports

Volumn 8, Issue 6, 2001, Pages 1225-1227

  Matsumoto, Yoshinari ^a   Ishiko, Osamu ^b   Sumi, Toshiyuki ^b   Yoshida, Hiroyuki ^b   Deguchi, Masaaki ^c   Nakagawa, Eri ^b   Haba, Tomoko ^b   Wakasa, Kenichi ^b   Ogita, Sachio ^b   Ando, Yoshiya ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

COX 2; Uterine adenosarcoma; Uterine carcinosarcoma; Uterine sarcoma

Indexed keywords

CYCLOOXYGENASE 2; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN;

ADENOSARCOMA; ARTICLE; CARCINOSARCOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; SARCOMA; UTERUS CANCER;

ADENOSARCOMA; CARCINOSARCOMA; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SARCOMA; UTERINE NEOPLASMS;

EID: 0035513598     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.6.1225     Document Type: Article

References (17)

1. Needleman P, Turk J, Jakschik BA, Morrison AR and Lefkowith JB: Arachidonic acid metabolism. Annu Rev Biochem 55: 69-102, 1986.
2. Smith WL and Mamett LJ: Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta24: 1-17, 1991.
3. Vane JR, Bakhle YS and Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998.
4. Kujubu DA, Fletcher BS, Varnum BC, Lim RW and Herschman HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 15: 12866-12872, 1991.
5. Espey LL: Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 50: 233-238, 1994.
6. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF and Taketo MM: Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2. Cell 29: 803-809, 1996.
7. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 48: 6-29, 1998.
8. Fathalla MF: Incessant ovulation, a factor in ovarian neoplasia? Lancet 17:7716, 1971.
9. Russell SE, Mickey GI, Lowry WS, White P and Atkinson RJ: Allele loss from chromosome 17 in ovarian cancer. Oncogene 5: 1581-1583, 1990.
10. Eccles DM, Cranston G, Steel CM, Nakamura Y and Leonard RC: Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene 5: 1599-1601, 1990.
11. Newhouse ML, Berry G, Wagner JC and Turok ME: A study of the mortality of female asbestos workers. Br J Ind Med 29: 134-141, 1972.
12. Newhouse ML, Berry G and Wagner JC: Mortality of factory workers in east London 1933-1980. Br J Ind Med 42: 4-11, 1985.
13. Cramer DW, Welch WR, Scully RE and Wojciechowski CA: Ovarian cancer and talc: a case-control study. Cancer 50: 372-376, 1982.
14. Heaps JM, Nieberg RK and Berek JS: Malignant neoplasms arising in endometriosis. Obstet Gynecol 75: 1023-1028, 1990.
15. Brinton LA, Gridley G, Persson I, Baron J and Bergqvist A: Cancer risk after a hospital discharge diaenosis of endometriosis. Am J Obstet Gynecol 76: 572-579, 1997.
16. Shu XO, Brinton LA, Gao YT and Yuan JM: Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 49: 3670-3674, 1989.
17. Risch HA and Howe GR: Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 4: 447-451, 1995.